Nabumetone
Product Images NDC 50436-6046

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Nabumetone (NDC 50436-6046). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Unit Dose Services, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

6mna (5276f530 14bc 492d 974b 913fd06bf52e 02)

Chemical structure of 6-methoxy-2-naphthylacetic acid (6MNA), the active metabolite of nabumetone. The structure depicts a naphthalene ring system with a methoxy group and an acetic acid side chain.*

FDA Label Image

Table 1 (5276f530 14bc 492d 974b 913fd06bf52e 03)

A data table presenting pharmacokinetic parameters for Nabumetone in Young Adults and Elderly groups at two dosing levels (1,000 mg and 2,000 mg). Parameters include Tmax (hours), half-life (t1/2 in hours), clearance (CLss/F in mL/min), and volume of distribution (Vdss/F in liters) with mean ± standard deviation values.*

FDA Label Image

6mna Plasma Concentrations (5276f530 14bc 492d 974b 913fd06bf52e 04)

A line graph showing Nabumetone active metabolite (6MNA) plasma concentrations at steady state following once-daily dosing of Nabumetone at 1000 mg and 2000 mg. The concentration (mcg/mL) is plotted on the vertical axis, and time (hours) is on the horizontal axis. The graph includes curves for mean concentrations with ±2 standard deviations for both dosages, highlighted with different line styles and shaded regions.*

FDA Label Image

Metabolites (5276f530 14bc 492d 974b 913fd06bf52e 05)

A data table showing the percentage composition of various metabolites related to Nabumetone, including unchanged nabumetone, 6-methoxy-2-naphthylacetic acid (6MNA), 6-hydroxy-2-naphthylacetic acid (6HNA), their conjugated forms, and other minor metabolites, totaling 73% dose.*

FDA Label Image

Table 2 (5276f530 14bc 492d 974b 913fd06bf52e 06)

A data table summarizing the number of patients with osteoarthritis (OA) and rheumatoid arthritis (RA) treated with different doses of Nabumetone (500 mg, 1,000 mg, 1,500 mg, 2,000 mg) along with their mean/mode duration of treatment in years.*

FDA Label Image

Structural Formula Of Nabumetone (Image 01)

Chemical structure of the active ingredient Nabumetone showing its molecular formula (C15H16O2) and molecular weight (228.3). The structure includes a naphthalene derivative with a methoxy group and a ketone functional group attached to an aliphatic chain.*

FDA Label Image

Label Image (Lbl504366046)

Nabumetone 500 mg tablet packaging label containing 60 tablets. The label includes storage instructions, a controlled room temperature warning, and manufacturer details indicating Unit Dose Services, LLC in Miami, FL. It also displays placeholder text for NDC, manufacturing lot, expiration date, and manufacturer by Glennmark. The label features a regulatory Rx symbol.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.